Skip to Content

BNVA 150 (Boniva 150 mg)

Generic Name: ibandronate

Pill with imprint BNVA 150 is White, Elliptical / Oval and has been identified as Boniva 150 mg. It is supplied by Roche Laboratories.

Boniva is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BNVA 150

Boniva

Generic Name
ibandronate
Imprint
BNVA 150
Strength
150 mg
Color
White
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Roche Laboratories
Inactive Ingredients
lactose monohydrate, povidone k25, microcrystalline cellulose, stearic acid, silicon dioxide, titanium dioxide, magnesium silicate, polyethylene glycol 6000

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00004-0186 Roche
54868-5322 Physicians Total Care Inc. (repackager)
35356-0423 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.